Trial Profile
Study for efficacy and safety of intravitreal injection of bevacizumab (Avastin)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy; Neovascular glaucoma; Retinal disorders
- Focus Therapeutic Use
- 20 Jun 2016 Status changed from recruiting to completed.
- 13 Nov 2013 New trial record